Skip to Content

Pharmacotherapy of Cachexia

Edited by Karl G. Hofbauer, Stefan D. Anker, Akio Inui, Janet R. Nicholson

Contributors: Vickie E. Baracos, Andrew L. Clark, Ulrich Keller, John E. Morley, Kaspar Berneis, David J. Glass, Amie J. Dirks, Laura A. Coleman, Bengt Lindholm, Philip A. Poole-Wilson, Annemie Schols, Andrew J.S. Coats, Matthias John, PV Carroll, Mellar P. Davis, Piotr Ponikowski, Stephan Von Haehling, Wolfram Doehner, Aminah Jatoi, Daniel L. Marks, Marijke Brink, Carolina G. Goncalves, Simona Perboni, R.J.E. Skipworth, Claudine Falconnier, Sabine Stassburg, Charles P. Lambert, Lindsey Harle, Smitha Patiyil, Stefanie Possekel, Michael M. Meguid, William J. Evans, Julio C. U. Coelho, Adrian S. Dobs, Christiaan Leeuwenburgh, KCH Fearon, Ewa A. Jankowska, Waldemar Banasiak, Markus A. Ruegg, Ross Clark, Antonio L.C. Campos, Susumu Suzuki, Giovanni Mantovani, Yoshiyuki Takimoto, M. Dahele, Katrin Utech, Jonas Axelsson, Olof Heimburger, Abdul Rashid Qureshi, Tommy Cederholm, Peter Stenvinkel, Ergun Y. Uc, Shehzad Basaria, Thomas Meier

Published December 22nd 2005 by CRC Press – 608 pages

Purchasing Options:

Description

Although a wealth of information can be found scattered throughout periodicals and research papers, tracking down the most effective treatment for a heterogeneous syndrome such as cachexia can be problematic. Edited by experts in the field, with contributions from a multidisciplinary panel, Pharmacotherapy of Cachexia is the first book devoted solely to the treatment of cachexia with a focus on pharmacotherapeutic aspects.

The book discusses the various aspects of the syndrome and compares and contrasts its diverse treatment options. It explores the topic from a theoretical and practical perspective and provides an overview of currently available and future treatment. The first half of the book includes coverage of pathophysiology, associated diseases, and general therapeutic aspects. The subsequent sections devoted to pharmacotherapy cover drugs in clinical use, drugs in research and development, and the final section focuses on potential future advancements.

Numerous internationally recognized specialists have contributed chapters on the various aspects of cachexia to this book. Their critical evaluation of pathophysiological mechanisms, clinical features, and therapeutic options make it a valuable source of information on all aspects of this serious and life-threatening condition. Expert editorial guidance ensures minimal repetition of information and uniform presentation. Addressing the multiple disease processes associated with cachexia in an organized and useful way, the book is a comprehensive reference for the management of this recalcitrant and hard-to-treat syndrome.

Contents

PATHOPHYSIOLOGY OF CACHEXIA

Malnutrition and Cachexia, C.G. Goncalves, A.L.C. Campos, J.C.U. Coelho, S. Suzuki, and M.M. Meguid

Anorexia: Central and Peripheral Mechanisms, S. Perboni, G. Mantovani, A. Inui, and Y. Takimoto

Skeletal Muscle Atrophy and Hypertrophy, D.J. Glass

Skeletal Muscle Apoptosis in Cachexia and Aging, A.J. Dirks and C. Leeuwenburgh

Neurohormonal Factors, A.L. Clark

Cytokines and the Pathophysiology of Skeletal Muscle Atrophy, V.E. Baracos

DISEASES ASSOCIATED WITH CACHEXIA

Diseases Associated with Cachexia: Cancer, R.J.E. Skipworth, M. Dahele, and K.C.H. Fearon

Cachexia Associated with AIDS, K. Berneis and K. Utech

Rheumatoid Cachexia, L.A. Coleman

Chronic Kidney Disease, B. Lindholm, J. Axelsson, O. Heimbürger, A.R. Qureshi, T. Cederholm, and P. Stenvinkel

Cardiac Failure, P.A. Poole-Wilson

Chronic Obstructive Pulmonary Disease, A.M.W.J. Schols

Cachexia in Older Persons, J.E. Morley

GENERAL THERAPEUTIC ASPECTS

Treatment Goals, A.J.S. Coats

Nutritional Treatment of Cachexia, C. Falconnier and U. Keller

DRUGS IN CLINICAL USE

Appetite Stimulants, M. John

Cardiac Cachexia - Drugs in Clinical Use, S. Strassburg and S.D. Anker

ß2-Adrenergic Agonists in the Treatment of Muscle Atrophy, C.P. Lambert, E.Y. Uc, and W.J. Evans

Androgens, Anabolic Steroids, and Glucocorticoids, L. Harle, S. Basaria, and A.S. Dobs

Growth Hormone, P.V. Carroll

Anti-Inflammatory Agents in Cancer Cachexia, M.P. Davis

DRUGS IN RESEARCH AND DEVELOPMENT

The Yin and Yang of IGF-1 and Ghrelin, R.G. Clark

Erythropoietin -A Novel Therapeutic Option for Cachectic Patients, P. Ponikowski, E.A. Jankowska, and W. Banasiak

Statins, S. von Haehling and S.D. Anker

Xanthine Oxidase Inhibitors and Insulin Sensitizers, W. Doehner

Tumor Necrosis Factor Inhibitors in the Management of Cancer-Associated Weight Loss Syndrome, S. Patiyil and A. Jatoi

FUTURE DRUG TARGETS

Central Pharmacological Targets, D.L. Marks

The Ubiquitin-Proteasome Pathway, M. Brink

Peripheral Signaling Pathways Involved in Muscle Loss, S. Possekel, T. Meier, and M.A. Ruegg

Perspectives and Outlook, K.G. Hofbauer, S.D. Anker, A. Inui, and J.R. Nicholson

Name: Pharmacotherapy of Cachexia (Hardback) – CRC Press 
Description: Edited by Karl G. Hofbauer, Stefan D. Anker, Akio Inui, Janet R. NicholsonContributors: Vickie E. Baracos, Andrew L. Clark, Ulrich Keller, John E. Morley, Kaspar Berneis, David J. Glass, Amie J. Dirks, Laura A. Coleman, Bengt Lindholm, Philip A. Poole-Wilson, Annemie Schols, Andrew J.S. Coats, Matthias John, PV Carroll, Mellar P. Davis, Piotr Ponikowski, Stephan Von Haehling, Wolfram Doehner, Aminah Jatoi, Daniel L. Marks, Marijke Brink, Carolina G. Goncalves, Simona Perboni, R.J.E. Skipworth, Claudine Falconnier, Sabine Stassburg, Charles P. Lambert, Lindsey Harle, Smitha Patiyil, Stefanie Possekel, Michael M. Meguid, William J. Evans, Julio C. U. Coelho, Adrian S. Dobs, Christiaan Leeuwenburgh, KCH Fearon, Ewa A. Jankowska, Waldemar Banasiak, Markus A. Ruegg, Ross Clark, Antonio L.C. Campos, Susumu Suzuki, Giovanni Mantovani, Yoshiyuki Takimoto, M. Dahele, Katrin Utech, Jonas Axelsson, Olof Heimburger, Abdul Rashid Qureshi, Tommy Cederholm, Peter Stenvinkel, Ergun Y. Uc, Shehzad Basaria, Thomas Meier. Although a wealth of information can be found scattered throughout periodicals and research papers, tracking down the most effective treatment for a heterogeneous syndrome such as cachexia can be problematic. Edited by experts in the field, with...
Categories: Pharmacology, Oncology, Nutrition